Furthermore, in Hodgkins’ disease, CXCL1 chemoattraction of inflammatory cells contributes to a complex tumour–host cellular interplay that can result in suppression of cell-mediated cellular immune response and consequently, tumour progression (Skinnider and Mak, 2002). This evidence concerns the gene CXCL1 and neoplasm.